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Abstract
Background: Foreign-born, HIV-infected persons are at risk for sub-clinical parasitic infections acquired in their countries of
origin. The long-term consequences of co-infections can be severe, yet few data exist on parasitic infection prevalence in
this population.
Methodology/Principal Findings: This cross-sectional study evaluated 128 foreign-born persons at one HIV clinic. We
performed stool studies and serologic testing for strongyloidiasis, schistosomiasis, filarial infection, and Chagas disease
based on the patient’s country of birth. Eosinophilia and symptoms were examined as predictors of helminthic infection. Of
the 128 participants, 86 (67%) were male, and the median age was 40 years; 70 were Mexican/Latin American, 40 African,
and 18 from other countries or regions. Strongyloides stercoralis antibodies were detected in 33/128 (26%) individuals. Of the
52 persons from schistosomiasis-endemic countries, 15 (29%) had antibodies to schistosome antigens; 7 (47%) had
antibodies to S. haematobium, 5 (33%) to S. mansoni, and 3 (20%) to both species. Stool ova and parasite studies detected
helminths in 5/85 (6%) persons. None of the patients tested had evidence of Chagas disease (n=77) or filarial infection
(n=52). Eosinophilia .400 cells/mm
3 was associated with a positive schistosome antibody test (OR 4.5, 95% CI 1.1–19.0).
The only symptom significantly associated with strongyloidiasis was weight loss (OR 3.1, 95% CI 1.4–7.2).
Conclusions/Significance: Given the high prevalence of certain helminths and the potential lack of suggestive symptoms
and signs, selected screening for strongyloidiasis and schistosomiasis or use of empiric antiparasitic therapy may be
appropriate among foreign-born, HIV-infected patients. Identifying and treating helminth infections could prevent long-
term complications.
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Introduction
Human immunodeficiency virus (HIV) co-infection with
parasitic diseases is an issue not only in parasite-endemic countries
but also for persons who have migrated to more developed
countries such as the United States. HIV surveillance systems in
the United States do not routinely assess country of birth, so there
are limited data on the number of foreign-born case patients [1].
In 2008, 19% of new HIV diagnoses were made among Hispanics
(55% foreign-born), and data from Washington show foreign-born
Blacks had HIV diagnosis rates 2.8 times higher than native-born
Blacks [2,3]. A study in sexually transmitted diseases clinics found
equal HIV prevalence among native- and foreign-born persons
[4]. Refugees, asylees, and immigrants are also at risk for
strongyloidiasis, schistosomiasis, and other parasitic infections
acquired in their countries of origin. An estimated 2 billion people
worldwide are infected with soil-transmitted helminths and
schistosomiasis; pathogenic intestinal parasite infections are
commonly found in immigrants to developed countries including
up to 98% of Ethiopian immigrants to Israel [5–7]. In the United
States, an estimated 300,000 persons are infected with Trypanosoma
cruzi [8].
Certain parasitic infections (e.g., Cryptosporidium parvum, Isospora
belli, and S. stercoralis) are more prevalent among HIV-infected
patients particularly those with lower CD4+ cell counts [9–11].
Furthermore, many parasitic infections can persist for decades and
result in significant morbidity and mortality. Long-term conse-
quences include schistosomiasis-associated portal hypertension,
cardiac and gastrointestinal abnormalities from Chagas disease,
and disseminated strongyloidiasis in the setting of human T-cell
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HIV-infected patients can have more severe and protean sequelae
such as immune reconstitution syndromes from schistosomiasis
and strongyloidiasis, rare but potentially fatal strongyloides
hyperinfection, and more rapid development of hepatic fibrosis
from schistosomiasis [6,15–18]. Chagas disease reactivation in
HIV-infected persons can be lethal with manifestations including
meningo-encephalitis and acute myocarditis [19–21].
Despite the potentially severe complications from parasite co-
infection with HIV, there are few data on the prevalence of
parasitic disease in foreign-born persons with HIV residing in the
United States. Furthermore, although there are guidelines for
screening new refugees, there are no standards for how or when to
look for parasitic infections among foreign-born persons with HIV
who may have been in the United States for extended periods of
time [5,22]. Evaluating HIV-infected persons is complicated by
the lack of sensitivity of stool testing in schistosomiasis and the
many etiologies for eosinophilia in HIV-infected persons (includ-
ing dermatologic disease and low CD4+ cell counts) in addition to
those seen among HIV-uninfected persons (e.g. allergies, connec-
tive tissue disease) [23–25]. The first objective of the study was to
determine the prevalence of selected parasitic infections among
HIV-infected persons who live in the United States and were born
in developing countries. Because of the frequency of comorbid
illnesses resulting in abdominal symptoms or eosinophilia in HIV-
infected persons, our second objective was to evaluate whether
specific symptoms, signs or laboratory parameters are useful in
predicting parasitic infection.
Methods
Ethics statement
Written informed consent was obtained from each participant;
the study was approved by the Institutional Review Boards of
Emory University and the Centers for Disease Control and
Prevention (CDC). Each participant received $10 to compensate
them for their time and the blood draw. Treatment for parasitic
infections was not part of the study. Health care providers were
informed of positive results and, when necessary, arranged
treatment in conjunction with a tropical medicine expert.
Study design
Between July–September 2009, we enrolled patients in a cross-
sectional study at the Ponce de Leon Center in Atlanta, Georgia.
This program provides care for ,5,000 patients, most with nadir
CD4+ cell counts less than 200 cells/mm
3. On the day of their
clinic visit, all non-pregnant, HIV-infected patients greater than 17
years of age who were born in a developing country were invited
to participate. We questioned participants on demographics, risk
factors for parasitic infection, and symptoms within the prior year.
Medical records were reviewed for previous parasitic infection
diagnoses, use of combination antiretroviral therapy (cART),
physical examination findings from the last three clinic visits, and
laboratory testing (including the three most recent complete blood
counts [CBC] and a urinalysis for persons from schistosomiasis-
endemic countries). Eosinophilia was defined as .400 eosino-
phils/mm
3 on any of the CBCs; the highest absolute eosinophil
count was used for analysis. Hematuria was defined as .2 red
blood cells per high power field. The most recent CD4+ cell count
and HIV viral load (VL) results were used for analysis.
Laboratory testing
Serologic testing for parasitic diseases was performed at CDC in
the Division of Parasitic Diseases and Malaria. All participants
were tested for infection with S. stercoralis by enzyme immunoassay
using soluble antigens from third-stage larvae [26]. Among persons
with positive results on stool specimens, the test sensitivity is
,95%, but the specificity has not been precisely determined for
persons in non-endemic areas [13,26]. For those with strongyloi-
diasis for whom serum was available, testing for HTLV was done
at Quest Diagnostics (Tucker, GA). Persons from Mexico, Central
America, and South America were tested for Chagas disease using
an indirect fluorescent antibody (IFA) and a recombinant antigen
enzyme linked immunosorbent assay (ELISA; Chagatest recombi-
nante; Wiener, Argentina); polymerase chain reaction (PCR)
testing and confirmatory trypomastigote excreted-secreted anti-
gen-blot (TESA-blot) were performed for those with positive
serological test results. For persons from schistosomiasis-endemic
countries, Falcon assay screening test ELISA (FAST-ELISA) using
S. mansoni adult microsomal antigen was done with subsequent
Schistosoma enzyme-linked immunoelectrotransfer blot (immuno-
blot) species identification using S. mansoni and S. haematobium adult
worm microsomal antigens. These assays have .95% sensitivity
and nearly 100% specificity for both species [27,28]. Urine was
examined microscopically at CDC for ova and parasites and was
tested for Schistosoma circulating cathodic antigen (CCA) (Rapid
Medical Diagnostics, South Africa). Filarial IgG1 and IgG4 assays
were performed for patients from endemic areas, and those with a
history of seizures were tested for neurocysticercosis using T. solium
immunoblot. Three stool samples per patient were examined for
ova and parasites by concentrated wet mount and trichrome
staining (Protocol Parasitology Systems, Thermo Scientific,
Virginia) at the Grady Health Systems laboratory.
Statistical analysis
The sample size was calculated based on the number of foreign-
born persons who would come for a clinic visit during the study
dates and agree to participate in the study. Data were entered into
Excel 97-2003, and analysis was performed using SAS software,
Author Summary
Undiagnosed and untreated parasitic infections can have
severe consequences for human immunodeficiency virus
(HIV)-infected persons. An estimated 2 billion people
worldwide are infected with soil-transmitted helminths
and schistosomiasis, yet there are few data on the
prevalence in HIV-infected immigrants to more developed
countries. This information could help clinicians determine
what testing is needed and what signs or symptoms to
expect. We performed serologic, stool, and urine testing
for selected parasites in 128 foreign-born persons receiv-
ing care at an HIV clinic in Atlanta, Georgia. We found that
26% had serologic evidence of infection with Strongyloides
stercoralis and 29% had serologic evidence of schistoso-
miasis. Because these were likely chronic processes,
symptoms and signs were often absent; only weight loss
was significantly associated with strongyloidiasis. High
eosinophil counts were also associated with parasitic
infection. This study suggests the need for targeted
screening of foreign-born, HIV-infected persons for para-
sitic infections (mainly strongyloidiasis and schistosomia-
sis) or the use of empiric antiparasitic therapy, particularly
among those with unexplained eosinophilia. Although
there are established guidelines for screening of refugees,
health care providers should consider the risk of these
organisms in patients who have entered the United States
through other pathways.
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Wilcoxon rank-sum test to compare the characteristics of persons
with and without strongyloidiasis and schistosomiasis. Logistic
regression modeling was used to evaluate predictors of strongy-
loidiasis, schistosomiasis, and eosinophilia. All clinically relevant
and statistically significant (p#0.05) variables in univariable
analysis were initially included in the model and eliminated using
a step-down model-building approach.
Results
Patient characteristics
Of the 128 persons in the study (80% participation rate among
eligible persons invited to join the study), the median age was 40
years (range 19–64 years) and 86/128 (67%) were male (Table 1).
Participants came from 41 birth countries: 48 (38%) were from
Mexico; 40 (31%) from 20 African countries (including 8 from
Ethiopia and 4 each from Ivory Coast, Kenya, and Nigeria); and
22 (17%) from 9 Central and South American countries. The
median duration of time in the United States was 10.8 years (range
11 months–49 years); 19 (15%) persons were more recent arrivals
(#5 years in the country).
Although date of HIV infection was not known, HIV was
diagnosed a median of 5 years before the study began (range 0–
21years). The median CD4+ cell count was 307 cells/mm
3 (range
0–1757), and 40/128 (31%) had CD4+ cell counts less than 200
cells/mm
3. The median CD4+ cell count nadir was 67 cells/mm
3
(range 0–982) (Table 1). At study enrollment, 113/128 (88%) were
receiving cART; the median duration of time on cART was 4
years (range ,1–18). The HIV VL was undetectable in 95/128
(74%) persons, and the median detectable VL was 31,245 copies/
ml (range 120–564,000).
Parasitic disease testing and clinical characteristics of
infection
Serologic evidence of S. stercoralis infection was detected in 33
(26%) persons; none had larvae detected by stool examination.
These persons were born in Mexico (n=12), Honduras (n=4),
Ethiopia (n=3), El Salvador (n=2), Zambia (n=2), and one each
in Argentina, Congo, Cuba, Grenada, Guatemala, India, Kenya,
Niger, Tanzania, and Vietnam. Strongyloidiasis-infected persons
had been in the United States a median of 10.2 years; 4 (12%)
were more recent arrivals. The most common symptoms and signs
seen in persons with strongyloidiasis included weight loss (53%),
diarrhea (48%), fatigue (42%), and abdominal pain (36%)
(Table 2). Only weight loss was significantly associated with
infection (OR=3.1; 95% CI: 1.4–7.2) when controlling for CD4+
cell count and VL. None of the 26 strongyloidiasis-infected
individuals tested for HTLV had evidence of infection. Those with
strongyloidiasis had lower CD4+ cell counts (median 239; range
Table 1. Demographic and clinical characteristics of foreign-born, HIV-infected persons with and without parasite infections, 2009.
Total (n=128)
Infected with any
parasite (n=49)
Uninfected with any
parasite (n=79)
Age in years, median (range) 40 (19–64) 40 (21–62) 40 (19–64)
Male gender, N (%) 86 (67) 35 (71) 51 (65)
Regions/Countries of Origin, N (%)
--Mexico 48 (38) 15 (31) 33 (42)
--Africa 40 (31) 21 (43) 19 (24)
---- Western Africa 18 (14) 9 (18) 9 (11)
---- Eastern Africa 14 (11) 8 (16) 6 (8)
---- Southern Africa 5 (4) 2 (4) 3 (4)
---- Central Africa 3 (2) 2 (4) 1 (1)
--Central America 16 (13) 7 (14) 9 (11)
--Caribbean 11 (9) 2 (4) 9 (11)
--Asia and Middle East 7 (6) 3 (6) 4 (5)
--South America 6 (5) 1 (2) 5 (6)
Years living in United States, median (range) 10.8 (0.9–48.7) 9.6 (1.3–35.6) 11.1 (0.9–48.7)
Years since HIV diagnosis, median (range) 5 (,1–21) 5 (,1–15) 5 (,1–21)
Years on cART, median (range) 4 (,1–18) 4 (,1–14) 4 (,1–18)
On cART at time of the study, N (%)
a 112 (89) 43 (88) 69 (90)
CD4+ count (cells/mm
3), median (range) 307 (0–1757) 194 (4–1159) 308 (0–1757)
CD4+ nadir (cells/mm
3), median (range) 67 (0–982)
b 79 (2–982) 64 (0–635)
Undetectable HIV VL, N (%)
Detectable HIV VL (copies/ml), median (range)
Eosinophil count (cells/mm
3), median (range)
95 (74)
31,245
(120–564,000)
196 (31–2304)
33 (67)
18,800
(120–529,000)
264 (0–2304)
62 (78)
41,000
(230–564,000)
176 (34–924)
Eosinophilia .400 cells/mm
3, n (%) 25 (20) 15 (31) 10 (13)
HIV, human immunodeficiency virus; cART, combination antiretroviral therapy; VL, viral load.
aData are missing for 2 persons.
bAlthough CD4+ cell count nadirs of ,200 cells/mm
3 or an AIDS diagnosis are generally required for entry into the clinic, we did not have all prior laboratory test results;
therefore, some reported nadirs are .200 cells/mm
3.
doi:10.1371/journal.pntd.0001034.t001
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1757), but the difference was not significant (p=0.16). Infection
was also not associated with age, duration of time in the United
States, or years since HIV diagnosis. Recalled history of walking
barefoot and employment as a farmer in the country of birth were
not statistically significant risk factors.
Among persons from endemic countries, schistosomiasis
antibody testing was positive in 15/52 (29%); 7 (47%) had
antibodies specific for S. haematobium antigens, 5 (33%) were
reactive to S. mansoni antigens, and 3 (20%) had antibody
reactivity to both species. Schistosomiasis had been previously
diagnosed in 1/15 persons with Schistosoma antibodies (49 years
earlier in Senegal); the patient was unsure whether he had been
treated. Schistosome-reactive antibody positive persons had been
in the United States a median of 6.8 years (including 6 more
recent arrivals) and primarily came from Ethiopia (n=3) and
Ivory Coast (n=2); the remainder came from other sub-Saharan
African countries (Cameroon, Congo, Democratic Republic of
the Congo, Liberia, Mali, Nigeria, Senegal, and Zambia) and one
from Iran. Polyuria (47%), fatigue (40%), diarrhea (33%), weight
loss (27%), and abdominal pain (27%) were the most common
signs and symptoms in persons with Schistosoma antibodies, but
none were significantly associated with a positive test for
schistosome-reactive antibodies. Although 4/11 (36%) for whom
prior urinalyses were available had documented hematuria, none
had ova detected on urine microscopic examination; 3/13 (two
with S. mansoni and one with S. haematobium) had detectable urine
CCA. Positive schistosome serology was not associated with age,
duration of residence in the United States, CD4+ cell count, or
amount of time since HIV diagnosis. Recalled history of
swimming or wading in water in the country of origin was not
a significant risk factor.
No participant had evidence of filarial infection; 11/52 (21%)
had equivocal or positive IgG1 testing (suggestive of exposure).
Only 1/11 (9%) was also equivocally IgG4-positive (suggestive of
possible infection), but the low IgG1 and equivocal IgG4 titers
made true infection unlikely. Among 77 persons tested for Chagas
disease (60 [78%] of whom reported living in thatch or adobe
houses), 3 (4%) had positive ELISA results (range .414–.721; cutoff
0.3) but negative results on IFA, PCR, and TESA blots. The
remaining 74 all tested negative by ELISA and IFA.
Stool samples were received from 85/128 (66%) participants; 5/
85 (6%) had infection or co-infection with one of several
pathogenic or potentially pathogenic intestinal parasites including
four with Entamoeba histolytica and/or E. dispar, and one each with
Blastocystis hominis and Hymenolepis nana [29]. Overall, 49/128 (38%)
had evidence of parasitic infection by either serologic or stool tests.
Positive testing for any parasitic infection was significantly
associated with having resided in Africa (OR=2.4; 95% CI:
1.1–5.1).
Eosinophilia
The median eosinophil count was 196 cells/mm
3 (range 0–
2304), and 25/126 (20%) had eosinophilia (.400 eosinophils/
mm
3). Eosinophil counts were significantly higher among those
with schistosome-specific antibodies than those without (median
320 v.142; p=.04) and among those with any one parasite
infection compared to those without (264 v. 176; p=.02). Higher
eosinophil counts were not significantly associated with strongy-
loidiasis, CD4+ cell count #200/mm
3, or having a detectable
Table 2. Signs, symptoms, and laboratory findings of foreign-born, HIV-infected persons with and without parasite infection.
Strongyloidiasis
(n=33)
a
Schistosomiasis
(n=15)
a
Persons without detectable
parasite infection (n=79)
b
Signs and Symptoms, n (%)
Weight loss 17 (53) 4 (27) 42 (41)
Diarrhea 16 (48) 5 (33) 26 (33)
Fatigue 14 (42) 6 (40) 29 (37)
Abdominal pain 12 (36) 4 (27) 15 (19)
Nausea or vomiting 5 (15) 4 (27) 20 (25)
Hematochezia 3 (9) 3 (20) 8 (10)
Abdominal tenderness on exam 3 (9) 0 5 (6)
Abdominal distension on exam 1 (3) 0 0
Hepatomegaly 1 (3) 0 1 (1)
Polyuria NA 7 (47) 26 (33)
Hematuria NA 1 (7) 2 (3)
Dysuria NA 1 (7) 5 (6)
Laboratory testing
CD4+ cell count (cells/mm
3), median (range) 239 (4–821) 334 (4–596) 308 (0–1757)
CD4+ cell count nadir (cells/mm
3), median (range) 68 (2–481) 54 (2–254) 64 (0–635)
Eosinophil count (cells/mm
3), median (range) 256 (0–2,304) 320 (55–704) 176 (34–924)
Eosinophilia .400 cells/mm
3, n (%) 8 (24) 7 (47) 10 (13)
Hematuria (documented)
c ND 4 (27) ND
HIV, human immunodeficiency virus; NA, Not applicable; ND, Not done.
a3 persons had schistosomiasis and strongyloidiasis and are included in both columns.
bColumn totals do not add to 128, as persons with positive stool ova/parasite tests are not included in any column.
cUrinalysis results were only recorded for persons from schistosomiasis-endemic countries.
doi:10.1371/journal.pntd.0001034.t002
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ly associated with having evidence of any parasite infection
(p=.01) but not with a positive serology for schistosomiasis
(p=.07) or comorbidities often associated with eosinophilia
(eosinophilic folliculitis [n=2], neoplasms [n=7], asthma
[n=5], and connective tissue disease [n=2]) or potentially
associated with eosinophilia (seasonal allergies [n=24]) [30]. In
logistic regression modeling controlling for seasonal allergies,
eosinophilia was associated with both schistosomiasis (OR=4.5;
95% CI: 1.1–19.0) and low CD4+ cell counts (OR=4.2; 95% CI:
1.0–17), although having a detectable HIV VL was not
significantly associated. In a separate model, eosinophilia was
associated with having any positive parasitic infection or serologic
test when controlling for CD4+ cell count and seasonal allergies
(OR=3.0; 95% CI: 1.2–7.4).
Discussion
Data have been lacking on the prevalence and indicators of
subclinical parasitic infection in HIV-infected, foreign-born
persons. To our knowledge, this is the first systematic study to
use serologic, stool and urine testing to examine this population in
the United States. We found that more than one-quarter of
participants from endemic countries had antibodies to strongyloi-
diasis or schistosomiasis. Clinical signs and symptoms may not be
useful predictors of chronic parasitic infection, but eosinophilia in
foreign-born, HIV-infected persons should not be ignored, as it
can signify schistosomiasis or another parasitic infection.
The high prevalence of antibody reactivity to parasitic infections
found in our study of HIV-infected, foreign-born persons is similar
to seroprevalences reported in other studies of migrant populations
(HIV-infected and uninfected) [31–34]. We confirmed earlier
findings that Africans may be at higher risk; Sarner et al. found
that .50% of persons migrating from Africa have at least one
positive parasite test, and others reported positive Schistosoma
antibodies in 11–17% of HIV-infected African immigrants
residing in the United Kingdom [31,33,34]. Sudanese and Somali
Bantu refugees have particularly high rates of infection; Schistosoma
antibodies have been found in 44% and 73% respectively
(although HIV testing was either not performed or reported)
[13]. The lack of Trypanosoma cruzi infections in our study is similar
to findings from other reports describing Latin American
immigrants [35]. Explanations include that we enrolled only 8
participants from countries with high seroprevalence (e.g. Bolivia,
Argentina, Paraguay, El Salvador, and Honduras), we did not
assess whether persons were from endemic areas within their
countries of origin, and we included few older participants who are
more likely to be seropositive [12,36,37]. The paucity of ova and
parasites detected in the stool may result from the duration of time
between likely exposure in the birth country and screening or from
less intense infection [31].
Given the high prevalence of certain parasite infections in our
study, our finding that eosinophilia was associated with positive
schistosomiasis serology and any positive parasite test may be
useful for HIV practitioners who must address the many possible
causes of eosinophilia in their patients. This result confirms studies
of African HIV-infected individuals in whom eosinophilia was
associated with antibodies to both strongyloidiasis and schistoso-
miasis, but this has not been a consistent finding in other studies of
HIV-infected persons [31,34,38]. Country of origin is clearly
important when addressing causes of eosinophilia. Although high
eosinophil counts have been associated with skin disease and
advanced HIV raising the suggestion that parasite evaluation is
not warranted, these investigators did not consider the patient’s
nationality [23,24]. Furthermore, the relationship between
eosinophilia and parasite infection status in our study may be
less subject to misclassification bias, since more sensitive serologic
testing was used in conjunction with stool studies that have poor
sensitivity especially in HIV-infected persons with schistosomiasis
[25].
In our study, clinical signs and symptoms were not reliable
indicators of parasite co-infection. Other than weight loss in
persons with strongyloidiasis, we found that no symptoms were
significantly associated with parasite infection. The lack of
associated abdominal pain has also been reported among HIV-
uninfected refugees and may be due to the chronicity of parasite
infection; associations with other signs and symptoms may not
have been apparent because of the high prevalence of signs and
symptoms due to other etiologies among HIV-infected persons
without parasitic infections [13,22].
Identifying and treating parasite co-infection in HIV-infected
patients should be an important consideration for clinicians in
developing and developed countries alike. Not only can HIV
infection result in potentially severe complications of parasitic
disease, but co-infection can affect HIV transmission and the
disease course. Schistosoma-infected individuals may have increased
HIV transmission rates because of elevated cytokine and HIV-
infected white blood cell levels in the semen of infected men and
ulcerative lesions in women with female genital schistosomiasis;
HIV vertical transmission is also more likely in helminth-infected
mothers [39–42]. In addition, co-infection may affect the course of
HIV disease. Although some studies present evidence to the
contrary, there are reports that treatment of helminth infections
decreases HIV VL which could affect HIV transmission and time
to AIDS-defining event or death [39,43–47].
Although our study was strengthened by the use of serologic and
urinary testing with excellent reported sensitivity and specificity, it
is notable that test characteristics are undefined for the same assays
when applied in patients with concomitant HIV [26,28]. Similarly,
persons co-infected with HIV and schistosomiasis excrete fewer
eggs, so urine microscopy may be less sensitive in this setting [39].
Schistosomiasis serological assays are also limited by not allowing
for differentiation between recent and old (potentially treated or
cleared) infections. It is therefore possible that we overestimated
infection rates, but this is unlikely because only one participant
reported possible treatment for schistosomiasis (and this was
almost 50 years prior). The remaining 14 (none of whom recalled a
diagnosis of or treatment for schistosomiasis) may have had
persistent or cleared infections. Cysticercosis serologic results may
have underestimated larval T. solium infection rates, as we only
tested persons with seizures, the most common manifestation of
neurocysticercosis; we can not make generalizations regarding the
overall prevalence of cysticercosis in the population studied. Lastly,
it is possible but unlikely that strongyloidiasis was acquired after
arrival in the country; to our knowledge, the last cases of domestic
infection were reported in 1981, but sexual transmission has been
reported [48,49].
Our study had other limitations. As is the case for retrospective
studies, our reliance on medical records for physical examination
data might have decreased our ability to detect associations
between infection and subtle clinical signs. Our sample size was
small, so we had low statistical power to detect associations
between infection and symptoms, signs and laboratory findings;
the sample size is comparable to previous studies and was
necessitated by the extensive serologic testing performed
[23,24,26]. Due to the descriptive nature of the study, we did
not control for multiple comparisons. Finally, with respect to the
generalizability of our findings, almost all persons receiving care at
Parasites in Foreign-Born, HIV-Infected Persons
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3,
and we had a large proportion of persons from Mexico; our results
may therefore not be fully applicable to the HIV-infected
population with higher CD4+ cell counts or from other countries.
Additional information about patients who chose not to participate
would also have helped us assess generalizability.
We found that HIV-infected, foreign-born persons are at high-
risk for sub-patent, chronic parasitic infections, particularly
strongyloidiasis and schistosomiasis, and classic symptoms and
signs may be lacking. Based on our study findings, we suggest the
implementation of targeted screening for foreign-born, HIV-
infected persons. Because of the risk of undiagnosed and untreated
disease, we recommend evaluation for or empiric guideline-
directed treatment of strongyloidiasis and schistosomiasis for all
persons from endemic areas, particularly those with eosinophilia
[50]. Some studies suggest that empiric therapy may be more cost-
effective than testing [51,52]. Screening for Chagas disease has
been recommended in patients with potential exposure history
such as immigrants from endemic parts of Mexico, Central, and
South America; other information on testing options and country-
specific parasitic disease risk is readily available [12,53–56].
Although there are established guidelines for screening refugees for
parasitic infections, health care providers should consider the risk
of these infections in persons who have entered the United States
through other pathways, particularly those with HIV infection
[13,22].
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